無料プレビュー

GSK plc (GSK) · New York Stock Exchange

プロフィール

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its

主要指標

株価: $46.54 (-1.02%)
時価総額: 932億ドル
PER（今期予想）: 9.8
PBR: 4.0
配当利回り: 3.90%
52週レンジ: $42.85 – $61.70
業種: Healthcare / Drug Manufacturers - General
上場: New York Stock Exchange
構成銘柄: —

比較会社: LLY Eli Lilly and Company、JNJ Johnson & Johnson、ABBV AbbVie Inc.、MRK Merck & Co., Inc.、NVS Novartis AG、AZN AstraZeneca PLC、AMGN Amgen Inc.、GILD Gilead Sciences, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-28 · 更新: 2026-10-09